[1]周思琪,程雨馨,张兴彩.基于网络药理学和分子对接技术探讨冬虫夏草治疗特发性肺间质纤维化的作用机制[J].西部中医药,2024,37(05):90-96.[doi:10.12174/j.issn.2096-9600.2024.05.17]
　ZHOU Siqi,CHENG Yuxin,ZHANG Xingcai.The Mechanism of Action of Dongchongxiacao in the Treatment of Idiopathic Pulmonary Fibrosis based on Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2024,37(05):90-96.[doi:10.12174/j.issn.2096-9600.2024.05.17]
点击复制

基于网络药理学和分子对接技术探讨冬虫夏草治疗特发性肺间质纤维化的作用机制

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年05期
页码:
90-96
栏目:
二次研究
出版日期:
2024-05-15

文章信息/Info

Title:
The Mechanism of Action of Dongchongxiacao in the Treatment of Idiopathic Pulmonary Fibrosis based on Network Pharmacology and Molecular Docking Technology
作者:
周思琪1, 程雨馨1, 张兴彩2
1.山东中医药大学，山东 济南 250014
2.山东中医药大学附属医院，山东 济南 250014
Author(s):
ZHOU Siqi1, CHENG Yuxin1, ZHANG Xingcai2
1.Shandong University of Traditional Chinese Medicine, Jinan 250014, China
2.Affiliated Hospital to Shandong University of Traditional Chinese Medicine, Jinan 250014, China
关键词:
特发性肺间质纤维化; 网络药理学; 信号通路; 分子对接; 冬虫夏草; 作用机制
Keywords:
idiopathic pulmonary fibrosis; network pharmacology; signaling pathway; molecular docking; mechanism of action
分类号:
R974
DOI:
10.12174/j.issn.2096-9600.2024.05.17
文献标志码:
A
摘要:
目的运用网络药理学和分子对接技术探究冬虫夏草治疗特发性肺间质纤维化（idiopathic pulmonary fibrosis，IPF）的作用机制。 方法通过中药系统药理学数据库与分析平台（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP）筛选出冬虫夏草的主要活性成分及其对应靶点；通过人类基因数据库（the human gene database，GeneCards）、在线人类孟德尔遗传数据库（online mendelian inheritance in man，OMIM）、DrugBank数据库检索获得IPF疾病相关靶点，取二者交集靶点作为冬虫夏草治疗IPF的关键作用靶点；将交集靶点上传至STRING数据库，构建冬虫夏草活性成分与IPF疾病的共同靶点蛋白-蛋白互作网络（protein-protein interactions，PPI），根据度值筛选出核心靶点；将交集靶点基因导入DAVID分析平台，进行基因本体（gene ontology，GO）、京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）通路富集分析。 结果共获得冬虫夏草活性成分7个，作用于IPF的关键靶点84个；关键活性成分有乙酸亚油酯、花生四烯酸、胆固醇、β-谷甾醇，核心靶点有J原癌基因、过氧化物酶体增殖物激活受体γ、丝裂原活化蛋白激酶14等，GO和KEGG富集分析显示主要通路有TNF、VEGF、p53、cAMP、MARK、鞘脂等信号通路，涉及癌症、细胞凋亡、炎症反应等多个生物进程。冬虫夏草活性成分与靶点蛋白可以形成稳定的复合物。 结论冬虫夏草对IPF的治疗作用具有多成分、多靶点、多通路的特点。
Abstract:
ObjectiveTo investigate the mechanism of action of Dongchongxiacao (cordyceps) in the treatment of idiopathic pulmonary fibrosis (IPF) using network pharmacology and molecular docking technology. MethodsThe main active ingredients of Dongchongxiacao and their corresponding targets were screened by traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP), and IPF-related targets were obtained by searching the human gene database (GeneCards), online mendelian inheritance in man (OMIM) database, and DrugBank database, and the intersection of the two targets was taken as the key target of the medicine in the treatment of IPF. The intersecting targets were uploaded to String database to construct a protein-protein interactions (PPI) network of active ingredients of the medicine and IPF, and the core targets were screened out according to the degree value. The intersecting target genes were imported into DAVID analysis platform for gene ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis. ResultsA total of seven active ingredients of the medicine were obtained, and 84 key targets acting on IPF. The key active ingredients were linoleyl acetate, arachidonic acid, cholesterol, β-sitosterol, and the core targets were J proto-oncogene (JUN), peroxisome proliferator-activated receptor γ (PPARG), mitogen-activated protein kinase 14 (MAPK14), etc. The GO and KEGG enrichment analyses showed that the main pathways were TNF, VEGF, p53, cAMP, MARK, sphingolipid and other signaling pathways, involving in multiple biological processes such as cancer, apoptosis, and inflammatory response. Active ingredients and target proteins of the medicine can form stable complexes. ConclusionThe therapeutic effects of the medicine on IPF is characterized by multi-components, multi-targets and multi-pathways.

相似文献/References:

[1]刘新宇,陈星宇,毕鸿昊,等.基于网络药理学和分子对接探讨枸杞子-菟丝子-当归治疗视网膜色素变性的作用机制[J].西部中医药,2025,38(12):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
　LIU Xinyu,CHEN Xingyu,BI Honghao,et al.Exploring the Mechanism of Action of Gouqizi-Tusizi-Angelica in the Treatment of Retinitis Pigmentosa Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(05):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
[2]赵靖昌,丛超,吴盼晴,等.基于网络药理学和分子对接技术探讨开郁种玉汤治疗非器质性女性不孕症的机制[J].西部中医药,2026,39(01):45.[doi:10.12174/j.issn.2096-9600.2026.01.10]
　ZHAO Jingchang,CONG Chao,WU Panqing,et al.Mechanism of Qi Stagnation-relieving Offspring-generating Decoction in the Treatment of Non-organic Female Infertility: Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2026,39(05):45.[doi:10.12174/j.issn.2096-9600.2026.01.10]
[3]杨雅婷,李宝玲,徐春悦,等.归脾汤基于肠道菌群治疗血管性痴呆的网络药理学研究[J].西部中医药,2026,39(01):79.[doi:10.12174/j.issn.2096-9600.2026.01.15]
　YANG Yating,LI Baoling,XU Chunyue,et al.Network Pharmacology-based Study on Guipi Decoction in Treating Vascular Dementia Based on Gut Microbiota[J].Western Journal of Traditional Chinese Medicine,2026,39(05):79.[doi:10.12174/j.issn.2096-9600.2026.01.15]
[4]田颢颐,田耘.基于网络药理学方法探讨活血药治疗IgA肾病的作用机制[J].西部中医药,2026,39(01):87.[doi:10.12174/j.issn.2096-9600.2026.01.16]
　TIAN Haoyi,TIAN Yun.Network Pharmacology-based Exploration into the Mechanism of Blood-activating Drugs in the Treatment of IgA Nephropathy[J].Western Journal of Traditional Chinese Medicine,2026,39(05):87.[doi:10.12174/j.issn.2096-9600.2026.01.16]
[5]李晓彤,李家立,曹志群,等.基于网络药理学和分子对接技术探讨参苓白术散治疗功能性腹泻的作用机制[J].西部中医药,2026,39(01):96.[doi:10.12174/j.issn.2096-9600.2026.01.17]
　LI Xiaotong,LI Jiali,CAO Zhiqun,et al.Mechanism of Shenling Baizhu Powder in Treating Functional Diarrhea Based on Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2026,39(05):96.[doi:10.12174/j.issn.2096-9600.2026.01.17]
[6]王嘉宁,王健.基于数据挖掘和网络药理学方法探讨惊恐障碍的中药治疗机制[J].西部中医药,2026,39(01):107.[doi:10.12174/j.issn.2096-9600.2026.01.18]
　WANG Jia?ning,WANG Jian.Mechanism of TCM Treatment for Panic Disorder Based on Data Mining and Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2026,39(05):107.[doi:10.12174/j.issn.2096-9600.2026.01.18]
[7]偶勇,古娜,晁旭.基于网络药理学探讨黄芪-莪术治疗肝癌的作用机制[J].西部中医药,2026,39(01):129.[doi:10.12174/j.issn.2096-9600.2026.01.21]
　OU Yong,GU Na,CHAO Xu.Network Pharmacology-based Exploration into the Mechanism of Huangqi-Ezhu in Treating Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2026,39(05):129.[doi:10.12174/j.issn.2096-9600.2026.01.21]
[8]韩燕鸿,李君,潘建科,等.基于网络药理学方法探讨丹参-牡丹皮配伍治疗膝骨性关节炎的作用机制[J].西部中医药,2026,39(01):65.[doi:10.12174/j.issn.2096-9600.2026.01.13]
　HAN Yanhong,LI Jun,PAN Jianke,et al.Network Pharmacology-based Discussion on the Mechanism of Danshen-Mudanpi Combination in Treating Knee Osteoarthritis[J].Western Journal of Traditional Chinese Medicine,2026,39(05):65.[doi:10.12174/j.issn.2096-9600.2026.01.13]
[9]黄小芮,刘建华,闫占峰,等.基于网络药理学与分子对接探讨苓桂术甘汤治疗良性阵发性位置性眩晕的机制[J].西部中医药,2026,39(03):108.[doi:10.12174/j.issn.2096-9600.2026.03.21]
　HUANG Xiaorui,LIU Jianhua,YAN Zhanfeng,et al.Network Pharmacology and Molecular Docking Based Exploration into the Mechanism of Lingguizhugan Decoction in the Treatment of Benign Paroxysmal Positional Vertigo[J].Western Journal of Traditional Chinese Medicine,2026,39(05):108.[doi:10.12174/j.issn.2096-9600.2026.03.21]
[10]王雪莹,李潇然,赵进喜,等.网络药理学与分子对接法探究鬼箭羽-牛蒡子药对治疗糖尿病肾病的机制[J].西部中医药,2026,39(03):115.[doi:10.12174/j.issn.2096-9600.2026.03.22]
　WANG Xueying,LI Xiaoran,ZHAO Jinxi,et al.Investigating the Mechanism of Guijianyu - Niubangzi Herb Pair Against Diabetic Kidney Disease Using Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2026,39(05):115.[doi:10.12174/j.issn.2096-9600.2026.03.22]

备注/Memo

备注/Memo:
周思琪（1996—），女，硕士学位，医师。研究方向：中医内科肺病的研究。国家自然科学基金应急管理项目（81641190）； 山东省自然科学基金面上项目（ZR2020MH351）；山东省医药卫生科技发展计划项目（2015WS0139）。
更新日期/Last Update: 2024-05-15